Monte Rosa Therapeutics (GLUE) Assets (2023 - 2025)
Historic Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $459.8 million.
- Monte Rosa Therapeutics' Assets rose 4594.42% to $459.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $459.8 million, marking a year-over-year increase of 4594.42%. This contributed to the annual value of $438.7 million for FY2024, which is 4443.61% up from last year.
- Latest data reveals that Monte Rosa Therapeutics reported Assets of $459.8 million as of Q3 2025, which was up 4594.42% from $359.6 million recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Assets registered a high of $459.8 million during Q3 2025, and its lowest value of $252.1 million during Q3 2023.
- In the last 3 years, Monte Rosa Therapeutics' Assets had a median value of $315.1 million in 2024 and averaged $338.3 million.
- As far as peak fluctuations go, Monte Rosa Therapeutics' Assets plummeted by 1368.23% in 2024, and later surged by 4740.58% in 2025.
- Over the past 3 years, Monte Rosa Therapeutics' Assets (Quarter) stood at $303.8 million in 2023, then surged by 44.44% to $438.7 million in 2024, then rose by 4.81% to $459.8 million in 2025.
- Its Assets stands at $459.8 million for Q3 2025, versus $359.6 million for Q2 2025 and $393.2 million for Q1 2025.